Skip to content

Article: Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings

Cockayne Syndrome Proteins Maintain Mitochondrial Health Through NAD+ Signaling: Preclinical Findings


Synopsis

Cockayne syndrome (CS) is a rare premature aging disorder involving DNA repair defects and mitochondrial dysfunction. Across human, mouse, and nematode models, mitochondrial dysfunction was a consistent feature. NAD+ supplementation improved lifespan and healthspan in nematode models, and NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) corrected mitochondrial issues in CS patient cells. The findings link DNA damage, mitochondrial dysfunction, and poor cellular cleanup processes (mitophagy/autophagy) as drivers of accelerated aging in CS—issues that can be partly reversed by restoring NAD+.

Journal

Aging Cell

Read more

Healthy Aging & Longevity

CD38 Deletion and Nicotinamide Riboside Supplementation Slow Axon Degeneration After Facial Nerve Injury: Preclinical Findings

Synopsis After facial nerve injury (axotomy), nerve function often does not fully recover due to axon degeneration, neuron death, and ongoing inflammation. CD38, an enzyme that breaks down NAD+, m...

Read more
Ataxia Telangiectasia

Nicotinamide Riboside Supplementation Enhances NAD+ Metabolism in Ataxia Telangiectasia: Clinical Findings

Objectives To study the metabolic effects of treatment with NR in a cohort of patients with ataxia-telangiectasia (AT). Journal Metabolites Key Outcomes NR-related pathways and metabolites signi...

Read more